Radioactive Fallout and Cancer: Lessons from Hiroshima, Nagasaki, Chernobyl, and Modern Conflict Risks

 

Radioactive Elements, Cancer Risk, and Historical Nuclear Incidents: Quantitative Risk Assessment and Implications for Modern Conflicts

Abstract

Radioactive elements are potent carcinogens due to their emission of ionizing radiation, which damages DNA and can induce malignancies. Historical nuclear events such as the atomic bombings of Hiroshima and Nagasaki, along with the Chernobyl nuclear disaster, provide critical epidemiological data for assessing radiation-induced cancer risk. This article synthesizes mechanisms of radiation-induced carcinogenesis, quantitative dose–response modeling, and historical cohort analyses, and extrapolates findings to contemporary conflict scenarios involving depleted uranium munitions or potential nuclear facility hazards, including the Middle East context. An annotated reference list provides robust scientific support.

1. Introduction

Radioactive elements, characterized by unstable atomic nuclei, emit ionizing radiation in the form of alpha, beta, or gamma rays. Unlike non-ionizing radiation, ionizing radiation carries sufficient energy to remove electrons from atoms, creating ions that can damage biological molecules. The health risks associated with radioactive exposure are most acutely observed in DNA damage, which, if not properly repaired, can initiate carcinogenesis.

In modern conflict contexts, the risk of radiation exposure arises both from military applications, such as depleted uranium (DU) munitions, and from potential attacks on nuclear facilities. Understanding cancer risk requires integrating data from historical incidents where populations were exposed to high levels of radiation, notably Hiroshima and Nagasaki (1945) and Chernobyl (1986). These events provide empirical data for dose-response modeling, which is crucial for estimating risk in contemporary low-dose exposures.

This article addresses:

1. Mechanisms of radiation-induced cancer
2. Quantitative dose-response modeling
3. Historical evidence from Hiroshima, Nagasaki, and Chernobyl
4. Risk assessment in modern conflict scenarios
5. Public health and policy implications

---

2. Mechanisms of Radiation-Induced Cancer

2.1 Ionizing Radiation and DNA Damage

Ionizing radiation produces free radicals that directly and indirectly damage cellular DNA. Damage manifests as:

• Single-strand breaks (SSBs): Generally repairable, minor effect if correctly repaired
• Double-strand breaks (DSBs): High risk of misrepair, can lead to mutations or chromosomal rearrangements
• Base modifications and crosslinking: Can disrupt gene transcription and replication

Persistent DNA damage can transform normal cells into cancerous cells, particularly when mutations affect oncogenes, tumor suppressor genes, or DNA repair genes.

2.2 Dose-Response Relationship

Radiation dose is quantified in sieverts (Sv), accounting for absorbed energy and radiation type. The Linear No-Threshold (LNT) model postulates a linear increase in cancer risk with dose, with no safe threshold:

$$Risk = \alpha \times Dose$$

Where $\alpha$ represents excess relative risk per unit dose. Data from Hiroshima/Nagasaki indicate:

• Leukemia: α ≈ 0.05–0.1 per Sv
• Solid cancers: α ≈ 0.04 per Sv

Age at exposure, dose rate, and radionuclide type significantly modify risk. For example, children exposed to Iodine-131 (Chernobyl) experienced dramatically higher thyroid cancer incidence.

2.3 Biological Modifiers

Factors affecting cancer risk include:

• Age: Younger individuals accumulate higher lifetime risk
• Sex: Differences in susceptibility exist; e.g., breast tissue radiation increases female risk
• Dose rate: Protracted low-dose exposures allow DNA repair, reducing per-unit dose risk
• Radionuclide type: Alpha emitters (like uranium isotopes) are highly damaging when internalized

---

3. Hiroshima and Nagasaki Atomic Bombings

3.1 Historical Context

• Dates: Hiroshima (August 6, 1945), Nagasaki (August 9, 1945)
• Detonation energy: ~15–21 kilotons TNT equivalent
• Immediate radiation: ~4–6 Gy near ground zero

Exposure included a high-intensity pulse of gamma and neutron radiation, followed by environmental fallout.

3.2 Life Span Study (LSS)

The Life Span Study cohort by RERF followed over 120,000 survivors, both exposed and unexposed. Key outcomes:

• Leukemia: Sharp increase within 2–5 years post-exposure
• Solid cancers: Linear increase with dose, persisting decades
• Excess relative risk: Dose-dependent, with α ≈ 0.05–0.2 per Sv

Quantitative modeling allows projection of excess lifetime cancer incidence:

• ~1% increase per 100 mSv for leukemia
• ~0.5% per 100 mSv for solid cancers

Annotated Reference:
RERF. (2012). Life Span Study of Atomic Bomb Survivors. Radiation Research, 177(3), 229–247.
Summary: Detailed cohort analysis confirms dose-dependent increase in leukemia and solid cancers; provides critical parameters for quantitative modeling.

---

4. Chernobyl Nuclear Disaster

4.1 Incident Overview

• Date: April 26, 1986
• Reactor explosion released ~5 exabecquerels of radioactivity, including I-131, Cs-137, Sr-90
• Exposure: Mixed, chronic (external and internal via ingestion/inhalation)

4.2 Health Outcomes

• Thyroid cancer: Dramatic rise in children, linked to I-131 exposure

• Leukemia: Observed in cleanup workers (liquidators) but statistically less clear
• Other solid tumors: Some elevation in long-term studies

Average thyroid doses ranged 0–50 Gy for children in contaminated zones.

Annotated Reference:
Cardis, E., et al. (2005). Estimates of Cancer Risks from the Chernobyl Accident. Radiation Research, 163(3), 247–259.
Summary: Dose-response modeling establishes strong correlation between I-131 exposure and thyroid cancer in children; supports extrapolation to low-dose risk assessment.

---

5. Depleted Uranium in Modern Conflicts

5.1 Properties and Uses

• DU: By-product of uranium enrichment, low U-235
• Utilized in munitions for armor-piercing capabilities
• Emits alpha radiation; highly toxic chemically

5.2 Health Evidence

• Animal studies: Internalized DU causes DNA damage and nephrotoxicity
• Epidemiology: Gulf War veterans and Iraq civilian populations show suggestive, but inconsistent genotoxic effects
• Risk modeling: Chronic low-dose DU exposure → theoretical lifetime cancer risk 0.01–0.05 per Sv

Annotated Reference:
UNSCEAR. (2000). Sources and Effects of Ionizing Radiation, Annex D. United Nations.
Summary: Reviews DU exposure studies and theoretical cancer risks; emphasizes uncertainties in population-level effects.

---

6. Quantitative Risk Modeling

6.1 Methodology

Using the LNT model and historical data:

• Acute high-dose exposure: Hiroshima/Nagasaki, 4–6 Gy → 0.2–0.5 excess lifetime cancer deaths per Sv
• Chronic low-dose exposure: DU inhalation, 0.1–0.5 Sv → 0.01–0.05 excess cancer deaths per Sv

6.2 Comparative Table

Scenario	Dose (Sv)	Excess Lifetime Cancer Risk	Notes
Hiroshima/Nagasaki	4–6	0.2–0.5	Acute, high-dose
Chernobyl (thyroid)	0–50	0.1–0.3	Internal I-131, chronic
DU battlefield exposure	0.1–0.5	0.01–0.05	Chronic, low-dose

6.3 Modern Scenario: Iran Conflict

• DU use or enrichment facility damage could expose workers to 1–5 Sv (localized)
• General population exposure would be much lower (<0.1 Sv)
• Risk modeling suggests measurable but small population-level cancer increase, mitigated by evacuation, shielding, and monitoring

---

7. Discussion

7.1 Key Insights

• Historical events provide robust dose-response data for acute exposures
• Chronic, low-dose exposures remain challenging to quantify; models provide theoretical estimates
• Depleted uranium exposure presents both radiological and chemical risk

7.2 Limitations

• Low-dose epidemiology is affected by confounding, migration, and mixed exposures
• Risk models (e.g., LNT) have uncertainty, especially for <100 mSv
• Data gaps exist for modern conflict scenarios due to lack of large, monitored cohorts

7.3 Policy Implications

• Transparent monitoring of radiation and health outcomes is essential
• International guidelines (IAEA, WHO, UNSCEAR) inform protective measures
• Mitigation strategies: shielding, evacuation, decontamination, public education

---

8. Conclusion

Ionizing radiation is a verified carcinogen with dose-dependent effects. Hiroshima, Nagasaki, and Chernobyl provide quantitative evidence for modeling risk. Modern conflict scenarios, such as potential DU exposure or nuclear facility damage, are theoretically hazardous but pose much lower risk than historical high-dose events. Ongoing monitoring, protective strategies, and public awareness are crucial for minimizing radiation-related health impacts.

---

Annotated References

1. RERF. (2012). Life Span Study of Atomic Bomb Survivors. Radiation Research, 177(3), 229–247.
   Comprehensive cohort study of 120,000 survivors; establishes dose-dependent risk for leukemia and solid cancers.
2. Cardis, E., et al. (2005). Estimates of Cancer Risks from the Chernobyl Accident. Radiation Research, 163(3), 247–259.
   Dose-response modeling confirms high thyroid cancer risk in children exposed to I-131.
3. UNSCEAR. (2000). Sources and Effects of Ionizing Radiation, Annex D. United Nations.
   Reviews depleted uranium exposure studies; highlights uncertainty in low-dose risk.
4. IAEA. (2006). Chernobyl’s Legacy: Health, Environmental and Socio-Economic Impacts.
   Official health outcomes report for affected populations and cleanup workers.
5. BEIR VII Committee. (2006). Health Risks from Exposure to Low Levels of Ionizing Radiation. National Academies Press.
   Comprehensive low-dose radiation risk assessment, provides LNT model parameters.
6. Shields, P., et al. (2010). Depleted Uranium Toxicology: Implications for Military Exposures. Toxicology, 278(2), 82–93.
   Reviews biological effects of DU, genotoxicity, and epidemiological evidence in veterans.
7. Little, M.P., et al. (2012). A Review of Dose-Response Models for Radiation-Induced Cancer. International Journal of Radiation Biology, 88(10), 743–759.
   Comparison of LNT, threshold, and hormesis models for radiation exposure.
8. WHO. (2006). Ionizing Radiation, Health Effects, and Protective Measures.
   Guidelines for public health response to radiation exposure.
9. UNSCEAR. (2016). Effects of Ionizing Radiation: 2016 Report to the General Assembly.
   Updates on long-term cancer incidence in exposed populations.
10. Darby, S.C., et al. (2005). Risk of Cancer from Low-Level Radiation Exposure. The Lancet, 365(9477), 1461–1467.
    Meta-analysis of low-dose exposures and excess relative risk estimates.

Article By: Brian Opiyo 

 

7 Hygiene Mistakes Almost Everyone Makes Daily (And What to Do Instead)

Introduction 

In a world where cleanliness is often equated with health, many people assume that the more they clean their bodies, the better. However, modern medical research shows that some common hygiene habits may actually do more harm than good.

From overwashing to using the wrong products, these everyday mistakes can disrupt your body’s natural balance, weaken your skin barrier, and even increase the risk of infections.

This article explores seven common hygiene mistakes, backed by science, and provides practical, doctor-approved alternatives to help you maintain optimal health.

Understanding Your Body’s Natural Balance

The human body is not meant to be sterile. Your skin and intimate areas host a complex ecosystem of beneficial microorganisms known as the microbiome. These bacteria play a crucial role in protecting against harmful pathogens, maintaining pH balance, and supporting overall health.

For example, healthy vaginal flora is dominated by Lactobacillus species, which help maintain an acidic environment (pH 3.5–4.5)[1]. Disrupting this balance can lead to infections such as bacterial vaginosis and yeast infections.

Similarly, your skin has a slightly acidic pH that acts as a natural defense barrier. When this balance is disturbed, irritation and inflammation can occur.

Understanding this concept is key: good hygiene is about balance, not excessive cleaning.

1. Overwashing Your Body

Many people believe that showering multiple times a day is beneficial, especially in hot climates or after sweating. However, excessive washing can strip your skin of its natural oils and protective bacteria[6].

Frequent use of soap—especially harsh soaps—can damage the skin barrier, leading to dryness, irritation, and increased sensitivity. Over time, this may make your skin more vulnerable to infections and environmental damage.

What to do instead:
Limit showers to once per day unless necessary. Use lukewarm water rather than hot water, and focus cleansing on areas prone to sweat, such as the underarms, feet, and groin.

2. Using Harsh or Scented Soaps

Scented soaps and body washes may smell pleasant, but they often contain chemicals that can irritate the skin and disrupt its natural pH[6].

Most traditional soaps are alkaline, while the skin’s natural pH is slightly acidic. This mismatch can weaken the skin’s protective barrier, leading to dryness, itching, and inflammation. Fragrances and artificial additives can also trigger allergic reactions in sensitive individuals.

What to do instead:
Choose mild, fragrance-free, and pH-balanced cleansers. These products clean without stripping away essential oils or disrupting your skin’s natural balance.

3. Washing Inside the Vagina (Douching)

One of the most widespread hygiene myths is that the vagina needs internal cleaning. In reality, the vagina is self-cleaning and does not require douching or internal washing[1][2][7].

Douching can disrupt the natural bacterial balance, eliminating beneficial bacteria and allowing harmful organisms to thrive. This can increase the risk of infections such as bacterial vaginosis, yeast infections, and pelvic inflammatory disease.

What to do instead:
Clean only the external genital area (the vulva) using water or a mild cleanser. Avoid inserting any products inside the vagina unless prescribed by a healthcare professional.

4. Overcleaning Intimate Areas

Even without douching, washing the intimate area too frequently can cause problems. Many people wash multiple times a day to prevent odor, but this can actually make things worse[8].

Excessive cleaning can dry out sensitive tissues, disrupt natural flora, and increase the risk of irritation and infection.

What to do instead:
Wash the intimate area once daily under normal conditions. During menstruation or after heavy sweating, washing twice daily may be appropriate—but avoid overdoing it.

5. Wearing Tight, Non-Breathable Underwear

Clothing choices play a significant role in hygiene. Tight-fitting or synthetic underwear can trap heat and moisture, creating an environment where bacteria and yeast can thrive[8].

This is particularly important for intimate health, as warm and moist conditions can increase the likelihood of infections and irritation.

What to do instead:
Opt for loose-fitting, breathable underwear made from natural fabrics like cotton. Change underwear daily, and avoid staying in sweaty clothes for extended periods.

6. Using Feminine Hygiene Products Unnecessarily

The market for feminine hygiene products has grown significantly, offering everything from scented sprays to wipes and washes. While these products are heavily marketed, many are unnecessary and can even be harmful[8].

They often contain fragrances, preservatives, and other chemicals that disrupt the natural microbiome and pH balance. This can lead to irritation, allergic reactions, and increased infection risk.

What to do instead:
Keep your routine simple. In most cases, water and a gentle cleanser are sufficient. Avoid using products with strong fragrances or unnecessary additives.

7. Not Drying Properly After Washing

After washing, many people overlook the importance of thoroughly drying their bodies. Moisture left on the skin—especially in folds or intimate areas—can create an ideal environment for fungal and bacterial growth[6][8].

This can lead to issues such as skin irritation, unpleasant odors, and infections.

What to do instead:
After bathing, gently pat your skin dry with a clean towel. Pay special attention to areas like the groin, underarms, and between skin folds. Avoid aggressive rubbing, as this can irritate the skin.

The Science Behind Healthy Hygiene

The key takeaway is that hygiene is not about eliminating all bacteria—it is about maintaining a healthy balance. Your body relies on beneficial microorganisms to protect against harmful ones. Disrupting this balance through excessive cleaning or harsh products can weaken your natural defenses.

Maintaining proper hygiene involves:

• Supporting your body’s natural pH
• Preserving beneficial bacteria
• Avoiding unnecessary chemical exposure

When these factors are in balance, your body is better equipped to protect itself.

A Simple, Healthy Hygiene Routine

To maintain good hygiene without harming your body, follow these basic guidelines:

• Shower once daily using lukewarm water
• Use mild, fragrance-free cleansers
• Avoid douching and internal cleansing
• Wear breathable, clean clothing
• Dry your body thoroughly after washing
• Keep your routine simple and consistent

When to Seek Medical Advice

While many hygiene-related issues can be resolved by adjusting your routine, some symptoms may require medical attention. Consult a healthcare professional if you experience:

• Persistent itching or irritation
• Unusual or strong odors
• Abnormal discharge
• Pain or discomfort

These symptoms may indicate an underlying condition that requires proper diagnosis and treatment.

Final Thoughts

Hygiene is essential for good health—but more is not always better. Many common habits, often believed to be beneficial, can disrupt your body’s natural balance and lead to long-term issues.

The goal of hygiene should not be to sterilize your body, but to support its natural protective systems. By avoiding these common mistakes and adopting a balanced approach, you can maintain healthier skin, better intimate health, and overall well-being.

Quick Summary

Avoid these common hygiene mistakes:

1. Overwashing your body
2. Using harsh or scented soaps
3. Douching
4. Overcleaning intimate areas
5. Wearing tight, non-breathable underwear
6. Using unnecessary hygiene products
7. Not drying properly

---

References

1. American College of Obstetricians and Gynecologists (ACOG) – Vaginal Health & Hygiene Guidelines: https://www.acog.org/womens-health/faqs/vaginitis
2. CDC – Bacterial Vaginosis (BV): https://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm
3. World Health Organization – Personal Hygiene & Health: https://www.who.int
4. Cleveland Clinic – Vaginal Care & Hygiene Advice: https://my.clevelandclinic.org
5. Mayo Clinic – Personal Hygiene & Skin Care: https://www.mayoclinic.org
6. NHS – Keeping Your Vagina Clean and Healthy: https://www.nhs.uk
7. International Journal of Women's Health – Impact of Feminine Hygiene Products on Vaginal Health: https://www.ijwh.org

By Brian Opiyo

Tumor Microenvironment Fuels Cancer Growth (The Hidden Physiology of Tumor Support Systems)

 

Introduction: The Living Ecosystem Inside a Tumor

When most people think of cancer, they imagine a mass of rogue cells dividing uncontrollably. But in reality, tumors are not just clumps of cancer cells — they are miniature ecosystems. Within each tumor lies a complex network of blood vessels, immune cells, fibroblasts, and connective tissues, all interacting in ways that can either suppress or promote cancer growth. This surrounding “neighborhood” is called the Tumor Microenvironment (TME) [1].

The TME plays a central role in the physiology of cancer: it controls how tumors access nutrients, evade the immune system, spread to other organs, and even resist treatments. Understanding the TME helps explain why cancer behaves the way it does — and how modern therapies can disrupt this deadly alliance.

1. What Is the Tumor Microenvironment?

The tumor microenvironment refers to all the non-cancerous components that surround and interact with tumor cells. These include:

• Blood vessels that deliver oxygen and nutrients

• Fibroblasts that remodel connective tissue

• Immune cells such as macrophages and lymphocytes

• Extracellular matrix (ECM) — the structural “scaffold” of tissues

• Signaling molecules, such as growth factors, cytokines, and enzymes

Together, these elements form a dynamic ecosystem. Cancer cells continuously send signals to these surrounding components, reprogramming them to create a supportive physiological environment that favors tumor growth [2].

2. How the Microenvironment Promotes Tumor Growth

Cancer cells cannot thrive in isolation. They depend heavily on their surroundings for oxygen, nutrients, and protection. Here are some of the major ways the TME supports cancer progression:

a) Angiogenesis — Growing New Blood Vessels

One of the most critical steps in tumor development is angiogenesis — the process of forming new blood vessels. Cancer cells secrete vascular endothelial growth factor (VEGF), which signals nearby capillaries to sprout new branches into the tumor mass [3].

This newly formed network of blood vessels provides oxygen and nutrients, allowing the tumor to expand beyond the limits of normal tissue. However, these tumor vessels are often abnormal and leaky, creating regions of low oxygen (hypoxia) that further stimulate cancer cell survival and mutation [4].

b) Hypoxia and Cellular Adaptation

Hypoxia (low oxygen levels) is one of the defining features of a growing tumor. When oxygen becomes scarce, cancer cells activate a protein called HIF-1α (Hypoxia-Inducible Factor 1-alpha), which helps them adapt by:

• Increasing glucose uptake

• Shifting metabolism to anaerobic glycolysis

• Stimulating more angiogenesis

This shift is often called the “Warburg effect” — where cancer cells prefer producing energy from glucose even without oxygen [5]. This not only helps them survive in low-oxygen conditions but also creates an acidic environment that promotes invasion and metastasis.

c) Immune Cell Reprogramming

The body’s immune system is meant to destroy abnormal cells. However, within the tumor microenvironment, certain immune cells are reprogrammed to support rather than fight the cancer.

For example, tumor-associated macrophages (TAMs) release growth factors and enzymes that enhance blood vessel formation and tissue remodeling [6]. They also suppress T-cells — the immune system’s main “cancer killers” — preventing an effective immune attack.

This immune evasion allows tumors to persist even in the presence of an active immune system.

d) Cancer-Associated Fibroblasts (CAFs)

Fibroblasts are connective tissue cells that normally help repair wounds. But within tumors, they transform into cancer-associated fibroblasts (CAFs). These cells produce excess collagen and matrix metalloproteinases (MMPs) that break down the extracellular matrix, clearing paths for cancer invasion [7].

CAFs also secrete growth signals like TGF-β and IL-6, fueling inflammation and accelerating cancer cell proliferation.

3. The Extracellular Matrix (ECM): More Than Just Structure

The extracellular matrix was once thought to be a passive scaffold. We now know it actively regulates cancer behavior.

In normal tissues, the ECM provides balance between stiffness and elasticity. But in tumors, the ECM becomes abnormally stiff, due to excess collagen deposition and cross-linking. This stiffness triggers mechanical signals that drive cancer cells to become more invasive [8].

Additionally, enzymes such as lysyl oxidase (LOX) modify the ECM and help cancer cells “sense” their environment. These signals can alter gene expression and promote metastasis — the spread of cancer to distant organs.

4. Communication Within the Tumor Ecosystem

Tumor and stromal cells constantly exchange information through chemical messengers and vesicles. One key player is the exosome — a microscopic bubble that carries proteins, RNA, and other molecules between cells [9].

Exosomes help cancer cells manipulate immune cells, promote angiogenesis, and even prepare distant organs for metastasis (the “pre-metastatic niche”).

This intercellular communication is one of the most fascinating physiological discoveries of the last decade — showing that cancer behaves more like a coordinated tissue than a group of rogue cells.

5. Drug Resistance and the Protective Microenvironment

One of the biggest challenges in oncology is why cancers resist therapy. The TME is often to blame.

Dense collagen and abnormal blood vessels limit drug penetration. Meanwhile, hypoxic zones reduce the effectiveness of radiation therapy (which depends on oxygen to generate free radicals).

Moreover, stromal cells secrete survival factors that help tumor cells recover after chemotherapy [10]. This is why modern cancer research increasingly focuses on targeting the microenvironment along with the tumor itself.

6. Targeting the Tumor Microenvironment: New Therapies

Recent breakthroughs aim to disrupt the TME to make tumors more vulnerable:

• Anti-angiogenic drugs like bevacizumab block VEGF to starve the tumor.

• Immunotherapies (e.g., checkpoint inhibitors) reactivate T-cells that were silenced by the tumor.

• Matrix-modifying agents are being tested to loosen ECM stiffness and improve drug delivery [11].

• Nanomedicine approaches are being designed to deliver therapies directly to TME components.

These strategies mark a major shift — from fighting cancer cells alone to dismantling the entire ecosystem that supports them.

Conclusion: The Tumor as a Living Organ

The tumor microenvironment represents one of the greatest frontiers in modern physiology. It reveals that cancer is not just a genetic disease but a systemic failure of tissue organization and communication.

By studying and targeting the TME, scientists are uncovering ways to make treatments more precise and effective — turning cancer’s own “support system” against it.

Understanding this microenvironment is key not only for developing new therapies but also for predicting how tumors will behave and respond to treatment.

References

1. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of Cancer: The Next Generation. Cell, 144(5), 646–674.

2. Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19(11), 1423–1437.

3. Carmeliet, P., & Jain, R. K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature, 473(7347), 298–307.

4. Vaupel, P., & Mayer, A. (2017). Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Reviews, 36(4), 887–897.

5. Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324(5930), 1029–1033.

6. Mantovani, A., et al. (2017). Tumor-associated macrophages as treatment targets in oncology. Nature Reviews Clinical Oncology, 14(7), 399–416.

7. Kalluri, R. (2016). The biology and function of fibroblasts in cancer. Nature Reviews Cancer, 16(9), 582–598.

8. Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014). The extracellular matrix modulates the hallmarks of cancer. EMBO Reports, 15(12), 1243–1253.

9. Wortzel, I., et al. (2019). Exosome-mediated communication in the tumor microenvironment. Cancer Letters, 458, 10–18.

10. Junttila, M. R., & de Sauvage, F. J. (2013). Influence of tumor micro-environment heterogeneity on therapeutic response. Nature, 501(7467), 346–354.

11. Mpekris, F., et al. (2020). Improving cancer therapy by normalizing the physical microenvironment. Nature Reviews Cancer, 20(12), 758–773.

Article By Brian Opiyo